Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 367 | 1,537 | 1,545 | 910 | 0 |
| Gross Profit | 367 | 1,537 | 1,545 | 910 | 0 |
| Operating Expenses | 38,315 | 34,605 | 31,110 | 28,650 | 34,285 |
| Operating Income | -37,948 | -33,068 | -29,565 | -27,740 | -34,285 |
| Other Income | 176 | 70 | -225 | 111 | 85 |
| Pre-tax Income | -37,772 | -32,998 | -29,790 | -27,629 | -34,200 |
| Income Tax | -56 | 126 | 28 | 45 | 220 |
| Net Income Continuous | -37,716 | -33,124 | -29,818 | -27,674 | -34,420 |
| Net Income | $-37,716 | $-33,124 | $-29,818 | $-27,674 | $-34,420 |
| EPS Basic Total Ops | -22.75 | -19.50 | -19.75 | -18.50 | -27.25 |
| EPS Basic Continuous Ops | -22.67 | -19.53 | -19.82 | -18.48 | -27.35 |
| EPS Diluted Total Ops | -22.75 | -19.50 | -19.75 | -18.50 | -27.25 |
| EPS Diluted Continuous Ops | -22.67 | -19.53 | -19.82 | -18.48 | -27.35 |
| EBITDA(a) | $-36,912 | $-32,099 | $-28,616 | $-26,830 | $-33,349 |